Skip to main content
. 2016 Apr 25;9(3):184–190. doi: 10.1016/j.tranon.2016.03.004

Table 2.

Frequencies of Protein Expression in Particular CTC Groups



CTC EP
CTC EMT
CTC Any
Protein Expression Negative N (%) Positive N (%) P Value Negative N (%) Positive N (%) P Value Negative N (%) Positive N (%) P Value
APC Negative 77 (46.7) 9 (52.9) .622 76 (48.1) 8 (27.6) .041 71 (48.6) 15 (34.9) .112
Positive 88 (53.3) 8 (47.1) 82 (51.9) 21 (72.4) 75 (51.4) 28 (65.1)
ADAM23 Negative 40 (24.2) 6 (35.3) .318 39 (24.8) 8 (26.7) .833 34 (23.4) 13 (29.5) .412
Positive 125 (75.8) 11 (64.7) 118 (75.2) 22 (73.3) 111 (76.6) 31 (70.5)
CXCL12 Negative 39 (23.5) 3 (17.6) .585 40 (25.2) 3 (10.3) .081 40 (27.2) 5 (11.6) .035
Positive 127 (76.5) 14 (82.4) 119 (74.8) 26 (89.7) 107 (72.8) 38 (88.4)
E-cadherin Negative 59 (39.9) 11 (64.7) .050 61 (42.4) 11 (42.3) .996 53 (40.2) 21 (52.5) .167
Positive 89 (60.1) 6 (35.3) 83 (57.6) 15 (57.7) 79 (59.8) 19 (47.5)
RASSF1* Negative 20 (31.7) 3 (27.3) .767 23 (32.4) 1 (12.5) .246 20 (31.3) 4 (23.5) .535
Positive 43 (68.3) 8 (72.7) 48 (67.6) 7 (87.5) 44 (68.8) 13 (76.5)
SYK Negative 63 (38.0) 5 (29.4) .488 58 (36.7) 12 (40.0) .732 54 (37.0) 16 (36.4) .940
Positive 103 (62.0) 12 (70.6) 100 (63.3) 18 (60.0) 92 (63.0) 28 (63.6)
TIMP3 Negative 79 (48.2) 12 (75.0) .040 80 (51.3) 13 (44.8) .523 71 (49.0) 23 (54.8) .508
Positive 85 (51.8) 4 (25.0) 76 (48.7) 16 (55.2) 74 (51.0) 19 (45.2)
BRMS1 Negative 11 (6.7) 2 (11.8) .447 14 (9.0) 2 (6.9) .715 12 (8.3) 4 (9.3) .842
Positive 152 (93.3) 15 (88.2) 142 (91.0) 27 (93.1) 132 (91.7) 39 (90.7)
SOCS1 Negative 5 (3.0) 6 (35.3) < .001 11 (7.0) 1 (3.4) .478 5 (3.4) 7 (16.3) .002
Positive 160 (97.0) 11 (64.7) 147 (93.0) 28 (96.6) 141 (96.6) 36 (83.7)

Number of samples analyzed in the study was n = 203; only successfully analyzed samples were included in the table.

*

For RASSF1, protein analyses were performed on 61 samples only because of the lack of material (tumor tissue).